Middle East and Africa Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Middle East and Africa Insulin Delivery Devices Market is Segmented Into Type (insulin Pumps, Insulin Syringes, Disposable Insulin Pens, Insulin Cartridges in Reusable Pens, And Insulin Jet Injectors) and Geography (Egypt, Iran, Oman, Rest of Middle East and Africa, Saudi Arabia, South Africa). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Middle East and Africa Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Middle East And Africa Insulin Delivery Devices Market Size

View Global Report
Middle East And Africa Insulin Delivery Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 2.02 Billion
Market Size (2030) USD 2.34 Billion
CAGR (2025 - 2030) 2.99 %

Major Players

Middle East And Africa Insulin Delivery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Middle East And Africa Insulin Delivery Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Middle East And Africa Insulin Delivery Devices Market Analysis

The Middle East And Africa Insulin Delivery Devices Market size is estimated at USD 2.02 billion in 2025, and is expected to reach USD 2.34 billion by 2030, at a CAGR of 2.99% during the forecast period (2025-2030).

An insulin infusion pump works as an alternative to the traditional system of daily injections or an insulin pen. Insulin infusion pumps reduce the large swings in blood glucose levels, lessen pain, and deliver more accurately than injections. The scheduling of meal timings is not required when using pumps. This makes infusion pumps more user-friendly for patients. Insulin therapy is also known as continuous subcutaneous insulin infusion (CSII). It is an efficient and flexible method of insulin delivery.

The advancement of technology has greatly enhanced the effectiveness of insulin delivery devices, resulting in improved management of glucose levels. Despite this progress, a majority of individuals who require insulin still rely on traditional methods such as syringes or traditional pens. Engaging in a conversation with your healthcare provider regarding these modern devices could greatly simplify the process of administering insulin.

In recent decades, technological advancements and innovative solutions have paved the way for a variety of insulin delivery devices, aiming to alleviate the difficulties and burdens associated with insulin administration. These devices range from simple patches to automated insulin delivery (AID) systems. However, it is noteworthy that a significant portion of insulin users still opt for the traditional combination of insulin bottles, syringes, or conventional insulin pens.

Technological advancements have increased over the period in Insulin delivery devices for safer and more accurate administration of insulin. Medtronic launched an Extended infusion set that leverages advanced materials that help reduce insulin preservative loss and maintains insulin flow and stability. The set is compatible with all MiniMed 600 and 700 series insulin pumps. The new tubing connector improves the physical and chemical stability of insulin, reliability of infusion site performance, and reduces the risk of infusion set occlusion. In addition to the new infusion set, the Medtronic Extended reservoir is also tested and approved to keep insulin stable and safely used for up to 7 days.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Middle East And Africa Insulin Delivery Devices Industry Overview

The Middle East and Africa insulin delivery devices market is moderately consolidated in nature due to the presence of only a few major companies like Novo Nordisk, Sanofi, Eli Lily and Company, Medtronic, Insulet, Ypsomped, Becton Dickinson & Company, etc. operating globally and other regional players.

Middle East And Africa Insulin Delivery Devices Market Leaders

  1. Becton and Dickinson

  2. Medtronic PLC

  3. Novo Nordisk A/S

  4. Sanofi Aventis

  5. Eli Lilly and Company

  6. *Disclaimer: Major Players sorted in no particular order
Middle East And Africa Insulin Delivery Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Middle East And Africa Insulin Delivery Devices Market News

  • January 2024: PharmaSens, a medical devices manufacturer headquartered in Switzerland, has recently filed an application with the US Food and Drug Administration (FDA) to seek approval for its innovative insulin patch pump system called 'niia essential'. This development marks a major achievement for PharmaSens in the progression of insulin pump technology.
  • October 2022: Novo Nordisk announced headline results from the ONWARDS 5 phase 3a trial with once-weekly insulin icodec in people with type-2 diabetes. The ONWARDS 5 trial was a 52-week, open-label efficacy and safety treat-to-target trial investigating once-weekly insulin versus once-daily basal insulin (insulin degludec or insulin glargine U100/U300).

MEA Insulin Delivery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Type
    • 5.1.1 Insulin Pumps
    • 5.1.1.1 Insulin Pump Device
    • 5.1.1.2 Reservoir
    • 5.1.1.3 Infusion Sets
    • 5.1.2 Insulin Syringes
    • 5.1.3 Insulin Disposable Pens
    • 5.1.4 Insulin Cartridges in Reusable Pens
    • 5.1.5 Jet Injectors
  • 5.2 Geography
    • 5.2.1 Egypt
    • 5.2.2 Iran
    • 5.2.3 Oman
    • 5.2.4 Rest of Middle East and Africa
    • 5.2.5 Saudi Arabia
    • 5.2.6 South Africa

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Novo Nordisk A/S
    • 7.1.2 Sanofi
    • 7.1.3 Eli Lilly and Company
    • 7.1.4 Medtronic PLC
    • 7.1.5 Insulet Corporation
    • 7.1.6 Ypsomed
    • 7.1.7 Becton Dickinson and Company
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Novo Nordisk A/S
    • 7.2.2 Sanofi
    • 7.2.3 Eli Lilly and Company
    • 7.2.4 Other Company Share Analyses

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
*The report covers a segment-wise breakdown (Value and Volume) for all the countries covered under Table of Contents **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Middle East And Africa Insulin Delivery Devices Industry Segmentation

There are different ways to inject insulin into a patient's body using syringes, pens, pumps, and jet injectors, giving them various options for insulin delivery. The Middle East and Africa insulin delivery devices market is segmented into type and geography. The report offers the value (in USD) and volume (in units) for the above segments. 

Type Insulin Pumps Insulin Pump Device
Reservoir
Infusion Sets
Insulin Syringes
Insulin Disposable Pens
Insulin Cartridges in Reusable Pens
Jet Injectors
Geography Egypt
Iran
Oman
Rest of Middle East and Africa
Saudi Arabia
South Africa
Need A Different Region or Segment?
Customize Now

MEA Insulin Delivery Devices Market Research FAQs

How big is the Middle East And Africa Insulin Delivery Devices Market?

The Middle East And Africa Insulin Delivery Devices Market size is expected to reach USD 2.02 billion in 2025 and grow at a CAGR of 2.99% to reach USD 2.34 billion by 2030.

What is the current Middle East And Africa Insulin Delivery Devices Market size?

In 2025, the Middle East And Africa Insulin Delivery Devices Market size is expected to reach USD 2.02 billion.

Who are the key players in Middle East And Africa Insulin Delivery Devices Market?

Becton and Dickinson, Medtronic PLC, Novo Nordisk A/S, Sanofi Aventis and Eli Lilly and Company are the major companies operating in the Middle East And Africa Insulin Delivery Devices Market.

What years does this Middle East And Africa Insulin Delivery Devices Market cover, and what was the market size in 2024?

In 2024, the Middle East And Africa Insulin Delivery Devices Market size was estimated at USD 1.96 billion. The report covers the Middle East And Africa Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Middle East And Africa Insulin Delivery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Middle East and Africa Insulin Delivery Devices Industry Report

Statistics for the 2025 Middle East And Africa Insulin Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Middle East And Africa Insulin Delivery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.